Open Genomics Accelerates Rare-Disease Discovery

Hypothesis: reproducible open genome models will cut the median journey from candidate regulatory variant to validated mechanism by twenty-five percent in rare-disease networks. Compare prospective cohorts with matched historical pipelines. Faster results do not count if replication quality falls; speed and scientific validity must improve together.